IL-33: A tissue derived cytokine pathway involved in allergic inflammation and asthma

173Citations
Citations of this article
125Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Besides classic T cell-derived T-helper type 2 (Th2) cytokines such as IL-4, IL-5 and IL-13, tissue-produced cytokines such as thymic stromal lymphopoietin, IL-25 and IL-33 are now recognized as important contributors to allergic inflammation. IL-33 is produced by various tissue dwelling cells and broadly enhances allergic inflammation through its effects on hematopoietic cell types. The environmental or endogenous triggers that provoke IL-33 cellular release may be associated with infection, inflammation or tissue damage. This review summarizes the wide range of documented IL-33 activities on human cellular mediators of inflammation as well as genetic evidence that IL-33 contributes to disease. Finally, there will be a discussion of still unanswered questions regarding the mechanisms by which cytokine activity is generated and IL-33's relationship with other Th2-associated cytokines. Cite this as: D. E. Smith, Clinical & Experimental Allergy, 2010 (40) 200-208. © 2009 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Smith, D. E. (2010, February). IL-33: A tissue derived cytokine pathway involved in allergic inflammation and asthma. Clinical and Experimental Allergy. https://doi.org/10.1111/j.1365-2222.2009.03384.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free